{"&cites=12290633109847859973&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","url":"https://ard.bmj.com/content/73/3/492.short","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé FC Breedveld…"],"year":2014,"numCitations":2331,"pdf":"https://ard.bmj.com/content/annrheumdis/73/3/492.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=15630718529220191090&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ciNJ7q9369gJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15630718529220191090&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com","p":1,"exp":1596893545545},{"title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.39480","authors":["JA Singh","JA Singh KG Saag","JA Singh KG Saag SL Bridges Jr","JA Singh KG Saag SL Bridges Jr EA Akl…"],"year":2016,"numCitations":2044,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.39480","citationUrl":"http://scholar.google.com/scholar?cites=6477801428873898453&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:1emLJRTG5VkJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6477801428873898453&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the …","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.21641","authors":["JA Singh","JA Singh DE Furst","JA Singh DE Furst A Bharat","JA Singh DE Furst A Bharat JR Curtis…"],"year":2012,"numCitations":1833,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.21641","citationUrl":"http://scholar.google.com/scholar?cites=13006033363861880408&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:WL7dfW-2frQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13006033363861880408&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","url":"https://ard.bmj.com/content/76/6/960.abstract","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé J Bijlsma…"],"year":2017,"numCitations":1810,"pdf":"http://eprints.whiterose.ac.uk/116927/1/annrheumdis-2016-210715.pdf","citationUrl":"http://scholar.google.com/scholar?cites=532213958404936786&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:UhQ7f8bNYgcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=532213958404936786&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","url":"https://ard.bmj.com/content/75/1/3.short","authors":["JS Smolen","JS Smolen FC Breedveld","JS Smolen FC Breedveld GR Burmester…"],"year":2016,"numCitations":910,"pdf":"https://ard.bmj.com/content/75/1/3.short","citationUrl":"http://scholar.google.com/scholar?cites=13812551669387189479&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:51yNr48KsL8J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13812551669387189479&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update","url":"https://ard.bmj.com/content/75/3/499?intcmp=ard&type=1-A","authors":["L Gossec","L Gossec JS Smolen","L Gossec JS Smolen S Ramiro","L Gossec JS Smolen S Ramiro M De Wit…"],"year":2016,"numCitations":727,"pdf":"https://ard.bmj.com/content/75/3/499?intcmp=ard&type=1-A","citationUrl":"http://scholar.google.com/scholar?cites=6246331980846741321&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:STeIk9dtr1YJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6246331980846741321&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when …","url":"https://ard.bmj.com/content/72/10/1613.short","authors":["DH Yoo","DH Yoo P Hrycaj","DH Yoo P Hrycaj P Miranda","DH Yoo P Hrycaj P Miranda E Ramiterre…"],"year":2013,"numCitations":616,"pdf":"https://ard.bmj.com/content/72/10/1613.short","citationUrl":"http://scholar.google.com/scholar?cites=9116727334688143044&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:xDYuWjUfhX4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9116727334688143044&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.21649","authors":["J Anderson","J Anderson L Caplan","J Anderson L Caplan J Yazdany…"],"year":2012,"numCitations":579,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.21649","citationUrl":"http://scholar.google.com/scholar?cites=12166801732459275383&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:d6TXk7Yp2agJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12166801732459275383&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial","url":"https://www.sciencedirect.com/science/article/pii/S0140673613602500","authors":["C Gabay","C Gabay P Emery","C Gabay P Emery R Van Vollenhoven","C Gabay P Emery R Van Vollenhoven A Dikranian…"],"year":2013,"numCitations":557,"citationUrl":"http://scholar.google.com/scholar?cites=4679670845037491991&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Fzc28NaH8UAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4679670845037491991&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors …","url":"https://www.sciencedirect.com/science/article/pii/S014067361261424X","authors":["GR Burmester","GR Burmester R Blanco","GR Burmester R Blanco C Charles"],"year":2013,"numCitations":505,"citationUrl":"http://scholar.google.com/scholar?cites=1222990309883057794&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ghZTCDXv-BAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1222990309883057794&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"}]}